Restricted
Summary
Developing next generation antivirals that engage the patient’s own immunity to naturally defend against viral infection without the emergence of drug resistance.
Documents
Restricted
Summary
Cerus Endovascular is engaged in the design and development of highly differentiated and proprietary interventional neuroradiology (INR) devices and delivery systems, which it believes will represent the next generation in the minimally invasive treatment of neurovascular diseases, particularly intracranial aneurysms.
Documents
Project Catalyst – Scheme of Arrangement for Cerus – 2 May 2023
Cerus Shareholder Letter – Feb 2023
Cerus Shareholder Letter – June 2022
Cerus Endovascular Receives US FDA 510(k) Clearance of its 027 Micro-catheter